{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:35:26Z","timestamp":1787070926548,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To assess the role of Accelerated Hypofractionated Chemoradiation for Locally Advanced Head &amp; Neck squamous cell cancer (HNSCC) during COVID 19 pandemic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      Previously untreated 20 patients with locally advanced HNSCC (Oral cavity\/oropharynx\/larynx\/hypopharynx) were treated with definitive hypofractionated radiotherapy of 60Gy in 25 fractions with concurrent cisplatin @35 mg\/m\n                      <jats:sup>2<\/jats:sup>\n                      once weekly for 5 weeks from March 2020 to November 2021. The patients were treated on 6MV LINAC with Volumetric modulated arc therapy (VMAT) by the Sequential boost technique and concurrent chemotherapy @35 mg\/m\n                      <jats:sup>2<\/jats:sup>\n                      . All the patients received 48Gy in 20 fractions to low-risk volume (CTV LR) in Phase I followed by 12Gy in 5 fractions boost to High-risk volume (CTV HR) in Phase II. The organs at risk (OARs) were contoured and appropriate constraints were given considering the hypofractionated regimen.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Out of 20 patients, most of the patients were Stage IV (15;75%) &amp; stage III 20%, out of which (55%) 11 were of the oral cavity, (40%) 8 were of the oropharynx, and (5%) 1 of larynx. All patients were treated with 60Gy\/25#\/5 weeks with the majority of the patients (17;85%) completing their treatment in less than 45 days. The Median follow-up was of 214 days. The locoregional control at 6 Months was 55%. Maximum acute toxicity was grade 3 mucositis which was observed in 18 (90%) patients. Ryle\u2019s tube feeding was needed in 11 (55%) patient. Out of 20 patients, 5 patients did not receive concurrent chemotherapy, and 8 (40%) patients received all 5 cycles of chemotherapy. 7, 35% of the patients could not complete all 5 cycles of concurrent chemotherapy due to grade 3 mucositis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>During a pandemic crisis with limited manpower &amp; technical resources accelerated hypofractionated radiotherapy with concurrent chemotherapy can be considered a feasible therapeutic option for HNSCC which can significantly reduce the overall Treatment Time (OTT) with comparable local control and manageable toxicities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_1747_22","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T01:00:27Z","timestamp":1695258027000},"page":"404-409","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Accelerated hypofractionated chemoradiation for locally advanced head and neck cancer during COVID 19 pandemic: A tertiary care experience"],"prefix":"10.4103","volume":"20","author":[{"given":"Sumit","family":"Agarwal","sequence":"first","affiliation":[{"name":"Department of Radiotherapy, AIIMS, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isha","family":"Jaiswal","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday P.","family":"Shahi","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Mandal","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit M.","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Jaiswal","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandlal","family":"Yadawa","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, AIIMS, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"key":"R2-20260507","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000446117","article-title":"Global epidemiology of head and neck cancers: A continuing challenge","volume":"91","author":"Gupta","year":"2016","journal-title":"Oncology"},{"key":"R3-20260507","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.aogh.2014.09.010","article-title":"Tobacco, alcohol, and cancer in low and high-income countries","volume":"80","author":"Lee","year":"2014","journal-title":"Ann Glob Health"},{"key":"R4-20260507","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol"},{"key":"R5-20260507","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.annonc.2020.03.296","article-title":"Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China","volume":"31","author":"Zhang","year":"2020","journal-title":"Ann Oncol"},{"key":"R6-20260507","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.radonc.2007.04.001","article-title":"Tumor progression in waiting time for radiotherapy in head and neck cancer","volume":"84","author":"Jensen","year":"2007","journal-title":"Radiother Oncol"},{"key":"R7-20260507","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0360-3016(95)00228-Q","article-title":"Local control of carcinoma of the tonsil by radiation therapy: An analysis of patterns of fractionation in nine institutions","volume":"15","author":"Withers","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R8-20260507","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0167-8140(01)00286-9","article-title":"Local control of T3N0 glottic carcinoma by 60 Gy given over five weeks in 2.4 Gy daily fractions. One more point on the biological effective dose (BED) curve","volume":"59","author":"Jackson","year":"2001","journal-title":"Radiother Oncol"},{"key":"R9-20260507","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","article-title":"Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis","volume":"368","author":"Bourhis","year":"2006","journal-title":"Lancet"},{"key":"R10-20260507","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0167-8140(99)00131-0","article-title":"Definitive radiotherapy for 114 cases of T3N0 glottic carcinoma: Influence of dose-volume parameters on outcome","volume":"53","author":"Wylie","year":"1999","journal-title":"Radiother Oncol"},{"key":"R11-20260507","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/archotol.1980.00790350039011","article-title":"Management of T3 glottic cancer","volume":"106","author":"Harwood","year":"1980","journal-title":"Arch Otolaryngol"},{"key":"R12-20260507","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2019.01.018","article-title":"Selection of lymph node target volumes for definitive head and neck radiation therapy: A 2019 update","volume":"134","author":"Biau","year":"2019","journal-title":"Radiother Oncol"},{"key":"R13-20260507","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"R14-20260507","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/0284186X.2014.958528","article-title":"Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinoma","volume":"54","author":"Thomson","year":"2015","journal-title":"Acta Oncol"},{"key":"R15-20260507","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/annonc\/mdy036","article-title":"Results of a multi-institutional, randomized, non-inferiority, phase III trial of accelerated fractionation versus standard fractionation in radiation therapy for T1-2N0M0 glottic cancer: Japan Clinical Oncology Group Study (JCOG0701)","volume":"29","author":"Kodaira","year":"2018","journal-title":"Ann Oncol"},{"key":"R16-20260507","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1470-2045(09)70306-7","article-title":"Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial","volume":"11","author":"Tobias","year":"2010","journal-title":"Lancet Oncol"},{"key":"R17-20260507","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1186\/s12885-018-4893-5","article-title":"Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma","volume":"18","author":"Jacinto","year":"2018","journal-title":"BMC Cancer"},{"issue":"991","key":"R18-20260507","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1259\/bjr\/31372149","article-title":"21 years of biologically effective dose","volume":"83","author":"Fowler","year":"2010","journal-title":"Br J Radiol"},{"key":"R19-20260507","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ijrobp.2020.04.016","article-title":"Practice recommendations for risk-adapted head and neck cancer radiation therapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement","volume":"107","author":"Thomson","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1747_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:39:02Z","timestamp":1787067542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1747_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1747_22","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,21]]},"assertion":[{"value":"2022-08-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}